254 related articles for article (PubMed ID: 19813185)
21. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
[TBL] [Abstract][Full Text] [Related]
22. Nonalcoholic fatty liver disease.
Adams LA; Lindor KD
Ann Epidemiol; 2007 Nov; 17(11):863-9. PubMed ID: 17728149
[TBL] [Abstract][Full Text] [Related]
23. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
24. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562
[TBL] [Abstract][Full Text] [Related]
25. Fatty liver in adolescents on the U.S.-Mexico border.
Sharp DB; Santos LA; Cruz ML
J Am Acad Nurse Pract; 2009 Apr; 21(4):225-30. PubMed ID: 19366381
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
[TBL] [Abstract][Full Text] [Related]
28. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels.
Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
J Hepatol; 2007 Apr; 46(4):700-7. PubMed ID: 17150278
[TBL] [Abstract][Full Text] [Related]
29. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
[TBL] [Abstract][Full Text] [Related]
30. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
[TBL] [Abstract][Full Text] [Related]
31. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N; Younossi ZM
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
[TBL] [Abstract][Full Text] [Related]
32. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
[TBL] [Abstract][Full Text] [Related]
33. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
Trovato GM; Martines GF; Garozzo A; Tonzuso A; Timpanaro R; Pirri C; Trovato FM; Catalano D
Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
[TBL] [Abstract][Full Text] [Related]
34. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
Huang SC; Yang YJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
[TBL] [Abstract][Full Text] [Related]
35. Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population.
Sanal MG; Sarin SK
Diabetes Metab Syndr; 2011; 5(2):76-80. PubMed ID: 22813407
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population.
Perez M; Gonzáles L; Olarte R; Rodríguez NI; Tabares M; Salazar JP; Jaimes S; García RG; López-Jaramillo P
Prev Med; 2011 Feb; 52(2):174-7. PubMed ID: 21147154
[TBL] [Abstract][Full Text] [Related]
38. Current status of liver disease in Korea: nonalcoholic fatty liver disease.
Park SH
Korean J Hepatol; 2009 Dec; 15 Suppl 6():S34-9. PubMed ID: 20037278
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.
Caballería L; Pera G; Auladell MA; Torán P; Muñoz L; Miranda D; Alumà A; Casas JD; Sánchez C; Gil D; Aubà J; Tibau A; Canut S; Bernad J; Aizpurua MM
Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):24-32. PubMed ID: 19730384
[TBL] [Abstract][Full Text] [Related]
40. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
Abid A; Taha O; Nseir W; Farah R; Grosovski M; Assy N
J Hepatol; 2009 Nov; 51(5):918-24. PubMed ID: 19765850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
